Eisai
4523.T
#2301
Rank
A$11.77 B
Marketcap
A$41.75
Share price
2.66%
Change (1 day)
-7.35%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: A$0.75 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.06 Billion. In 2023 the company made an earning of A$0.75 Billion, an increase over its 2022 earnings that were of -A$32.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023A$0.75 B-2404.04%
2022-A$32.69 Million-103.6%
2021A$0.90 B-39.81%
2020A$1.50 B7.44%
2019A$1.40 B17.22%
2018A$1.19 B86.16%
2017A$0.64 B-23.52%
2016A$0.84 B26.97%
2015A$0.66 B22.3%
2014A$0.54 B-46.07%
2013A$1.00 B-21.85%
2012A$1.28 B-20.59%
2011A$1.62 B-8.91%
2010A$1.77 B19.21%
2009A$1.49 B